Health

Australia to buy extra 20 million doses of Pfizer vaccine

Fitness & Health:

Australia says it has finalized a deal to buy an extra 20 million doses of the Pfizer vaccine as it rapidly pivots away from its earlier plan to rely mainly on the AstraZeneca vaccine

CANBERRA, Australia — Australia said Friday that it has finalized a deal to buy an extra 20 million doses of the Pfizer vaccine as it rapidly pivots away from its earlier plan to rely mainly on the AstraZeneca vaccine.

He said the deal means Australia will get a total of 40 million doses of the Pfizer vaccine by the end of the year, enough to inoculate 20 million people in the nation of 26 million.

RELATED:  Amid COVID shutdowns, GOP's McCarthy attended son's wedding

After the European agency’s declaration, Australian drug regulators held a series of urgent meetings Thursday and recommended the Pfizer vaccine become the preferred vaccine for people under 50.

Morrison said there was no prohibition on the AstraZeneca vaccine and the risk of side effects was remote. He said the change was being made out of an abundance of caution.

The pivot represents a significant shift in Australia’s overall approach and is likely to delay plans to have everybody inoculated by October.

Even before the change, the government was facing criticism for a rollout program that’s lagging behind those in most other developed nations. So far, Australia has administered just over 1 million vaccine doses.

Opposition Leader Anthony Albanese said the rollout was a debacle and Australians needed certainty about when they would be vaccinated.

“This government has failed. This government couldn’t run a choko vine up a back fence,” Albanese told reporters, referring to a plant that produces pear-shaped fruit and grows easily in the Australian climate.

RELATED:  Variant surge at border forces Bangladesh into new lockdown

Health Minister Greg Hunt said there would be some adjustments but everybody would be kept safe and would get vaccinated.

Australia has managed to stamp out community spread of the virus, allowing life to continue much as before the pandemic.

AstraZeneca noted Australia’s decision to restrict the vaccine’s use was based on it having no community transmission.

“Overall, regulatory agencies have reaffirmed the vaccine offers a high-level of protection against all severities of COVID-19 and that these benefits continue to far outweigh the risks,” the company said in a statement.

DISCLAIMER:-If article is on fitness, health tips, beauty, tips-tricks care like recommendation, then check for DISCLAIMER in T&C.

Health News Today & Latest Medical News More Updates

Today News || Latest News || World News || US Politics || Health News || Technology News || Education News

Source

Tags
Show More

Related Articles

Back to top button
Close